Magnesium citrate is often preferred if constipation is a main issue, since it can help draw water into the bowels
Several GLP-1 medications are FDA-approved for either Type 2 diabetes or chronic weight management when certain conditions are met
Large glucose swings, visceral adiposity, fatty liver, and elevated fasting insulin may all signal a metabolic environment that is less favorable for long-term cognitive health
A lower mortality in the GLP-1 RA group would expectedly lead to an underestimation of the fracture risk in that group, thereby exaggerating a protective effect of GLP-1 RAs
There are several mechanisms by which these drugs result in weight loss, with MOST of the effect being related to hunger and satiety
Any reference to biological activity or potential effects is based solely on preclinical or invitro findings and should not be interpreted as validated clinical outcomes